Antitumor activity of lurbinectedin (PM01183) and doxorubicin in relapsed small-cell lung cancer: results from a phase I study von Calvo, E., Moreno, V., Flynn, M., Holgado, E., Olmedo, M.E., Lopez Criado, M.P., Kahatt, C., Lopez-Vilariño, J.A., Siguero, M., Fernandez-Teruel, C., Cullell-Young, M., Soto Matos-Pita, A., Forster, M.

Volltext

941TiP A phase I/IIa, open-label, dose-finding trial to evaluate safety, immunogenicity, and anti-tumour activity of VB10.16 in combination with pembrolizumab in patients with unre... von Khalique, S., Oliva, M., Even, C., Dziadziuszko, R., Dietz, A., Italiano, A., Melichar, B., Martinez-Galan, J., Brydøy, M., Thouvenin, J., Rutkowski, T., Hitre, E., Guix Arnau, M., Lopez Criado, M.P., Jürgens, T., Bratland, Å.

Volltext

147P Activity of single-agent PD-1/PD-L1 inhibitors in 1st-line (1L) “platinum-ineligible” patients (pts) with metastatic urothelial cancer (mUC) in real-life clinical practice von Molina Cerrillo, J., Ortego, I., Pinto Marin, A., Alonso Gordoa, T., Puente, J., Arranz Arija, J.A., Lopez Criado, M.P., Gonzalez Morales, A., Vidal Cassinello, N., Castellano Gauna, D.E., Sevillano Fernandez, E., Garcia Donas, J., Grande Pulido, E.

Volltext

MA 01.05 Activity and Safety of the Combination of PM01183 and Doxorubicin in Relapsed SCLC. Final Results of a Phase Ib Trial von Calvo, E., Forster, M., Moreno, V., Olmedo, M.E., Criado, M.P. Lopez, Lopez-Vilariño, J., Kahatt, C., Soto-Matos, A.

Volltext

Activity of lurbinectedin as single agent and in combination in patients with advanced small cell lung cancer (SCLC) von Olmedo Garcia, M.E., Forster, M., Calvo, E., Moreno, V., Lopez Criado, M.P., Lopez-Vilarino de Ramos, J.A., Kahatt, C., Lardelli, P., Luepke-Estefan, X.E., Soto-Matos, A.

Volltext

P1.12-20 Overall Survival with Lurbinectedin Plus Doxorubicin in Relapsed SCLC. Results from an Expansion Cohort of a Phase Ib Trial von Forster, M., Moreno, V., Calvo, E., Olmedo, M.E., Lopez-Criado, M.P., Lopez-Vilariño, J., Nuñez, R., Kahatt, C., Soto-Matos, A.

Volltext

Activity of lurbinectedin as single agent and in combination in patients with advanced small cell lung cancer (SCLC) von Forster, M., Olmedo, M.E., Calvo, E., Moreno, V., Lopez Criado, M.P., Lopez-Vilariño, J.A., Kahatt, C., Lardelli, P., Nuñez, R., Soto-Matos, A.

Volltext

166 - Activity of lurbinectedin as single agent and in combination in patients with advanced small cell lung cancer (SCLC) von Forster, M., Olmedo, M.E., Calvo, E., Moreno, V., Lopez Criado, M.P., Lopez-Vilariño, J.A., Kahatt, C., Lardelli, P., Nuñez, R., Soto-Matos, A.

Volltext

P2.01-022 Nintedanib/Docetaxel Efficacy in Advanced Lung Adenocarcinoma Treated with 1L Chemotherapy/2L Immunotherapy in Nintedanib NPU von Corral, J., Majem, M., Rodríguez-Abreu, D., Carcereny, E., Cortes, A. Artal, Llorente, M., Picazo, J.M. López, García, Y., Domine, M., Criado, M.P. Lopez

Volltext

196TiP A phase I study of REGN6569, a GITR monoclonal antibody (mAb), in combination with cemiplimab in patients with advanced solid tumour malignancies von Lakhani, N., Hamid, O., Braña, I., Reguera Puertas, P., Lopez Criado, M.P., Swiecicki, P.L., De Miguel Luken, M.J., Gil Martín, M., Khong, H., Moreno Garcia, V., Lostes Bardaji, M.J., Sun, F., Sandigursky, S., Zambrano, M., Cristea, M., Fury, M.

Volltext

MA04.01 Cemiplimab, a Human Monoclonal Anti-PD-1, Alone or in Combination with Radiotherapy: Phase 1 NSCLC Expansion Cohorts von Moreno, V., Gil-Martin, M., Johnson, M., Aljumaily, R., Lopez-Criado, M.P., Northfelt, D., Crittenden, M., Jabbour, S., Rosen, L., Calvo, E., Papadopoulos, K., Garrido, P., Hervás Morón, A., Rietschel, P., Mohan, K., Li, J., Stankevich, E., Feng, M., Lowy, I., Fury, M.

Volltext

2623 Prospective validation of prognostic classifications in patients (pt) progressing to first-line chemotherapy in metastatic transitional-cell carcinoma (mTCC) von Arija, J.A. Arranz, Vazquez-Estevez, S, Perez-Valderrama, B, del Muro, X. Garcia, Laínez Milagro, N, Sala, N, Fita, M.J. Juan, Noguerón, E, Sáez, M.I, Rey, P. Maroto, Font, A, Díaz, E. Gallardo, Méndez-Vidal, M.J, Criado, M.P. Lopez, Quintela, M. Lázaro, Marin, A. Pinto, del Alba, A. Gonzalez, Caro, R. Luque, Lobera, C. Santander, Martínez, I. Duran

Volltext

243P Concomitant administration of palbociclib and proton pump inhibitors affects clinical outcomes in metastatic breast cancer patients von Criado, J. Álvarez, Martinez, V.M., Aunon, M.P. Zamora, Peña-López, J., Sanchez, V.L. Collada, Espinosa, E., Hoyo-Muñoz, A., García-López, L., Mateos-Salillas, C., Perez, D. Martinez, Castelo, B., Ruiz-Gutiérrez, I., Cuesta, J.A. Garcia, Bou, D. Jiménez, Recio, S. Martinez, Barbas, J. Pedregosa, Feliu, J., Herrero, A.

Volltext

Patrones de frecuencia cardíaca fetal y su relación con la saturación de oxígeno del feto von Puertas, A., López-Criado, M.S., Navarro, M., González-Salmerón, M., Velasco, P., Tirado, M.P., Rodríguez, A., Miranda, J.A.

Volltext